Research suggests GLP-1 drugs like Ozempic and Wegovy could double divorce risk, mirroring trends seen in bariatric surgery patients, experts say.

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...

Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...

A recent FDA approval means consumers now have to GLP-1 weight loss pills to choose from as an alternative to the traditional ...

Genes may predict GLP-1 weight loss, linking genetic variants to treatment response and side effects in 27,885 patients using GLP-1 drugs.

Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are ...

Real-world study in type 2 diabetes suggests possible association, but more research is ne ...

"I find the consistency across age, race, BMI, and glycemic status more clinically exciting than the sex difference," said ...

Study finds GLP-1 receptor agonists do not increase pancreatitis risk and are associated with fewer complications in Type 2 ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that ...

As the number of people using these medications has soared, so have anecdotal reports about how they’re impacting users’ ...

GLP-1 drugs like Ozempic and Wegovy can aid weight loss and diabetes, but come with side effects, high costs and unanswered ...